What is Cannasouth Bioscience?
Cannasouth Bioscience is a New Zealand-based entity that has focused on the development and provision of medicinal cannabis products. Operating within a nascent industry in New Zealand, the company's objective was to cater to individuals seeking therapeutic alternatives through cannabis-derived solutions. It is important to note that Cannasouth was placed into receivership by its secured noteholders on May 22, 2025.
How much funding has Cannasouth Bioscience raised?
Cannasouth Bioscience has raised a total of $6M across 1 funding round:
Share Placement
$6M
Share Placement (2020): $6M, investors not publicly disclosed
What's next for Cannasouth Bioscience?
Given the company's placement into receivership on May 22, 2025, the future strategic direction is dictated by the receivership process rather than further investment or expansion. The prior enterprise-level funding and strategic investment were aimed at scaling operations and product development within the medicinal cannabis market. However, the current circumstances shift the focus to asset realization and creditor settlement.
See full Cannasouth Bioscience company page
